Our findings establish OSMR as a molecular linchpin connecting intrinsic tumor survival pathways (PI3K/CCNE2) with extrinsic immunosuppressive reprogramming (BMP5/TANs/CD8<sup>+</sup>T cells), providing a clinically actionable target to overcome treatment resistance in GC. The gene discussed is CCNE2; the disease is neoplasm.